Immunology
-
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
This article has 10 authors:Reviewed by ScreenIT
-
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
This article has 31 authors:Reviewed by ScreenIT
-
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
This article has 30 authors:Reviewed by ScreenIT
-
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
This article has 14 authors:Reviewed by ScreenIT
-
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice
This article has 15 authors:Reviewed by ScreenIT
-
Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein
This article has 8 authors:Reviewed by ScreenIT
-
Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
This article has 8 authors:Reviewed by ScreenIT
-
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 spike protein expressing epithelial cells promotes senescence associated secretory phenotype in endothelial cells and increased inflammatory response
This article has 4 authors:Reviewed by ScreenIT
-
A chicken IgY can efficiently inhibit the entry and replication of SARS-CoV-2 by targeting the ACE2 binding domain in vitro
This article has 7 authors:Reviewed by ScreenIT